NovaBay announces 1-for-35 reverse stock split

NovaBay Pharmaceuticals announced that, following approval from the company’s stockholders obtained at the company’s November 10, 2022 special stockholders’ meeting, the company’s Board of Directors has approved the filing of an amendment to the company’s Amended and Restated Certificate of Incorporation, as amended, to effect a 1-for-35 reverse stock split of all outstanding shares of common stock of the company. The company anticipates that the 1-for-35 reverse stock split will be effective as of 4:15 p.m. New York City Time on Tuesday, November 15, 2022, and the company’s common stock will begin trading on a split-adjusted basis on Wednesday, November 16, 2022.